Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant

Hum Immunol. 2011 Feb;72(2):139-43. doi: 10.1016/j.humimm.2010.11.008. Epub 2010 Nov 13.

Abstract

The CTLA-4 genetic variation, such as single nucleotide polymorphisms (SNPs) may be critical and can affect the functional activity of cells that initiate the graft-versus-host disease (GVHD) effects. The aim of this study is to examine the effect of donor CTLA-4 alleles and haplotypes for the -318C>T and the 49A>G polymorphisms on the occurrence of GVHD in Tunisians recipients of HSCs. A total of 112 patients and their 112 respective sibling donors of HSCs were enrolled in this study. All patients had either grades 0-I or grades II-IV acute GVHD, or chronic GVHD. The SNPs genotyping assay was performed using sets of sequence specific primers (SSP-PCR). The single marker association analysis showed that the 49G allele, in a genetic recessive model, may be a potential risk factor only for the chronic GVHD (p = 0.032, odds ratio [OR] = 2.58, 95% confidence interval = 1.05-6.32). The haplotypes analyses showed that the CTLA-4 -318C49G nucleotide combination is significantly associated with the incidence of chronic GVHD (p = 0.043, χ² = 3.27). Donor CTLA-4 -318C49G haplotype may be a significant risk factor for developing chronic GVHD after allo-stem cell transplantation. We suppose that donor T cells expressing this haplotype in a homozygous state have higher proliferation than those expressing other haplotypes, especially after recognition of the recipient's minor histocompatibility antigens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Alleles
  • Antigens, CD / genetics*
  • Antigens, CD / immunology
  • CTLA-4 Antigen
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Female
  • Gene Frequency / genetics
  • Gene Frequency / immunology*
  • Genetic Predisposition to Disease
  • Genotype
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / genetics*
  • Graft vs Host Disease / immunology*
  • HLA Antigens / genetics
  • HLA Antigens / immunology
  • Haplotypes / genetics
  • Haplotypes / immunology*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / physiopathology
  • Lymphoproliferative Disorders / therapy
  • Male
  • Middle Aged
  • Minor Histocompatibility Antigens / genetics
  • Minor Histocompatibility Antigens / immunology
  • Polymorphism, Single Nucleotide / genetics
  • Polymorphism, Single Nucleotide / immunology*
  • Risk Factors
  • Siblings
  • Tissue Donors
  • Transplantation, Homologous
  • Tunesien
  • Young Adult

Substances

  • Antigens, CD
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • HLA Antigens
  • Minor Histocompatibility Antigens